Market check: Tesla stock extends rally, Moderna shares decline

Yahoo Finance's Jared Blikre discusses trending tickers today including Tesla, Lucid, Nio, and Moderna.

Video Transcript

KARINA MITCHELL: And Jared, let's get right into it. You have been watching some of the market movers today, starting with Tesla eyeing its best four day rally since March.

JARED BLIKRE: Yes, and what a rally it's been, Karina. Let's pull up the YFi Interactive, where I can chart the price action for us. And now no real fundamental news today, but the stock has seen a lot of momentum recently. So let me pull up one month trailing chart here. And you can see we got liftoff only last week, along with a lot of other stocks that have been beaten down.

So this is actually if we pull up a four day chart, we can see it's up 23% over that time period. It had been in danger of getting stuck below $1,000 per share, kind of an important technical level. Now it's right back above 1,100, I believe the all time highs somewhere around 1,250.

And Tesla is not the only stock on top of our Wyeth trending ticker list. Today we also have Rivian, that stock up 8%. Lucid Motors is up 2%. And Lucid this year up 283%, recently added to the NASDAQ 100. But that is the best performing stock in the NASDAQ 100.

Now if we take a look at what's happened over the trailing month here, we can see we're getting some red. There NIO, which is also one of our trending tickers, today down 24% over that same time period. Lucid Motors, which we were just talking about, down 25%. And it's really the stalwart, some of the bigger names and especially the traditional automakers, that have been having a better go of it. But nevertheless, I'm going to put the four day chart in here you can see just about everything is green or dark green, Karina.

KARINA MITCHELL: And Jared, on the flip side of all of that, Moderna is heading for the longest streak of declines since October of 2019. I'm a little bit surprised by that.

JARED BLIKRE: Yeah, and healthcare itself has had a really good month so far. But if we go back to the YFi Interactive, I'm going to pull up Moderna. It's one of the few red spots on our screen here. This is another stock that has been a high flyer, but also you can see a 136% year today, but also very much off of its highs.

And if we put a two month chart here, you can see some of those declines. Down 27% over the period. Now, I'm going to scale out and I'm going to bring up our month-to-date view on the pharmaceutical sector. And we can see a lot of these names have been getting a lot of love. Notably not some of these vaccine names.

So if I sort by performance, we can see there at the bottom, Moderna off about 30%, BioNTech off 27%, Novavax off 24%. So really the traditional healthcare is what has been riding a lot of the gains for the sector this month. And by the way, healthcare is the leading sector month to date for December, Karina.

KARINA MITCHELL: And tech is also on a tear. Meta advancing as KeyBank sees strong holiday sales for Oculus.

JARED BLIKRE: That's right. And let's pull up the YFi Interactive one final time here, not for the entire show. But you can see Facebook is one of the contributors to this nice rally we have as a megacap, up 3 and 1/2%. Now over the last two months, you can see here, it's finally climbed back to that prior potential resistance area.

And then you can see this even better on a year-to-date basis. So not by those record highs that we had, say last quarter, but definitely on the way there. That's trading in the right direction. I do have some notes. You mentioned that KeyBank report.

They're saying that Oculus was likely a popular gift over the holiday season. That firm is cited the ranks-- excuse me, the rankings of the Oculus app in Apple's App Store, saying this suggests a solid Christmas selling season. Also noting that Oculus was a top five entertainment app in five countries and a top 10 overall app in the US on Christmas Eve.

So I know a couple of people, even in our audience here, not our audience, on our crew, who got an Oculus. And they said it's pretty incredible, Karina.

KARINA MITCHELL: I would not know what to do with an Oculus, Jared.

JARED BLIKRE: I don't think I will either.